NOV 24, 2018 10:54 PM PST

New Anti-Malarial Drug Target in Cancer

WRITTEN BY: Nouran Amin

For decades, anti-malaria drugs--known as Chloroquines, have used to treat cancer. But the role in repurposing these drugs for slowing tumor growth have never been quite understood until a recent research study in Cancer Discovery.

Credit: NaturalNews.com

The research, carried at out Abramson Cancer Center of the University of Pennsylvania, identified the chloroquines specific target in cancer – an enzyme called PPT1. Identifying that particular enzyme has opened the doors for potential cancer treatments. “The discovery of this target is critical because chloroquines are currently being evaluated in clinical trials all over the world, including here at Penn, and this knowledge fundamentally changes the way we look at those trials,” says study co-senior author and associate professor--Dr Ravi K. Amaravadi of the Perelman School of Medicine at the University of Pennsylvania.

The enzyme, PPT1, controls the target of rapamycin (mTOR)—which is highly involved in the growth of cancer cells as well as another cellular process known as autophagy—a way for cancer cells to detoxify and repair themselves. The mechanisms of autophagy was discovered by Nobel Prize winner-- Yoshinori Ohsumi, watch the video below to learn more:

In previous studies, autophagy was found to provide nutrient support for mTOR to direct cancer growth while, interestingly, mTOR was found to shut down autophagy when nutrients aren’t needed. Using these studies, the researchers utilized CRISPR/Cas9 gene editing approach to knockout PPT1 from cancer cells and observe if the same effects in earlier research can be seen. Results showed that indeed removing ppt1 does slow tumor growth. “The edited cells look like they’ve been treated with a drug, and they grow significantly slower than the unedited cells,” Prof Amaravadi said. “We also compiled data from existing databases and found PPT1 is both highly expressed in most cancers and also associated with poor outcomes.”

These findings encouraged researchers to develop potent chloroquine known as DC661, that will take advantage of this novel treatment pathway.

“We now have a specific molecular target in cancer, as well as a potent way to reach it,” Prof Amaravadi said. “It not only provides new context for current clinical trials involving hydroxychloroquine, but also, with further development of these compounds toward clinical drug candidates, it opens the door for head-to-head testing of our compounds or their optimized derivatives versus current chloroquines to see which is more effective.”

Source: Drug Target Review

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 04, 2020
Cardiology
JAN 04, 2020
New Protein Therapy Improves Heart Attack Survival Rates
Heart disease is the top killer in the Western world. This is partially because, if one manages to survive an initial heart attack, oftentimes the scar tis...
JAN 14, 2020
Cancer
JAN 14, 2020
Could the flu vaccine shrink cancer tumors?
If you’ve been to the doctor recently, you’ve probably been asked if you want a flu shot this year. The flu vaccine is popular because it reduc...
JAN 16, 2020
Drug Discovery & Development
JAN 16, 2020
Fatty Acid Supplement Repairs Brain After Stroke in Mice
Researchers have found that supplements containing short chain fatty acids (SCFAs) may be able to help the brain recover from having a stroke. This comes a...
JAN 20, 2020
Cell & Molecular Biology
JAN 20, 2020
Using Modified Red Blood Cells As a Drug Delivery System
For a drug to be effective, it has to get to the right place to exert its impact....
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
A New Drug Target for Substance Abuse
Research carried out by the University of Minnesota Medical School indicates a new drug target for treating a drug addiction. Researchers note that the dru...
MAR 06, 2020
Drug Discovery & Development
MAR 06, 2020
Scorpion-derived Proteins Deliver Arthritis Treatment
New research published in the journal Science Translational Medicine shows that that a scorpion-derived proteins could soon provide relief for arthritis. &...
Loading Comments...